TABLE 2.
Correlations with PDQ-39 change.
| No. | r | P | |
| UPDRS-III off | 40 | 0.152 | 0.348 |
| UPDRS-III temor | 40 | 0.314 | 0.049* |
| UPDRS-III rigidity | 40 | –0.030 | 0.855 |
| UPDRS-III bradykenisia | 40 | 0.021 | 0.898 |
| UPDRS-III PIGD | 40 | 0.134 | 0.408 |
| UPDRS-III (OFF-60 min) | 40 | 0.069 | 0.672 |
| UPDRS-III temor (OFF-60 min) | 26 | 0.494 | 0.010* |
| UPDRS-III rigidity (OFF-60 min) | 39 | –0.042 | 0.800 |
| UPDRS-III bradykenisia (OFF-60 min) | 40 | 0.027 | 0.871 |
| UPDRS-III PIGD (OFF-60 min) | 40 | –0.046 | 0.777 |
| UPDRS-III (OFF-120) | 40 | 0.102 | 0.530 |
| UPDRS-III temor (OFF-120) | 26 | 0.483 | 0.012* |
| UPDRS-III rigidity (OFF-120) | 39 | 0.100 | 0.546 |
| UPDRS-III bradykenisia (OFF-12O) | 40 | 0.027 | 0.871 |
| UPDRS-III PIGD (OFF-120) | 40 | 0.009 | 0.956 |
| Age | 40 | 0.188 | 0.246 |
| LEDD (mg) | 40 | –0.144 | 0.377 |
| MMSE | 40 | –0.393 | 0.012* |
| MOCA-B | 40 | –0.234 | 0.146 |
| Duration | 40 | 0.015 | 0.926 |
| NMS | 40 | 0.032 | 0.843 |
| PDQ-39 | 40 | 0.392 | 0.012* |
| GDS | 39 | –0.016 | 0.921 |
| BDI | 40 | 0.084 | 0.606 |
| SAS | 40 | 0.143 | 0.378 |
| SCPA-AUT | 40 | 0.095 | 0.559 |
| RBD | 40 | –0.113 | 0.488 |
MMSE, Mini-Mental State Exam; MoCA-B, Montreal Cognitive Assessment Basic; SAS, Self Rating Anxiety Scale; BDI, Beck Depression Inventory; GDS, Geriatric Depression Rating Scale; PDQ-39, 39-item Parkinson’s Disease Questionnaire; LEDD, levodopa equivalent dailydose; UPDRS-III, Unified Parkinson’s III total score; SCOPA-AUT, Parkinson’s disease autonomic dysfunction.
*P < 0.05.